Alto Neuroscience ANRO Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$63.24M-2.9% | -$61.43M-69.2% | ||
| $628K+10.8% | $567K+42.5% | ||
| $8.11M+6.3% | $7.63M+164% | ||
| -$51.77M-9.2% | -$47.42M-41.8% | ||
| —— | $2.08M+341% | ||
| —— | -$2.08M-341% | ||
| —— | $0— | ||
| $60.08M-55.8% | $135.93M+99.4% | ||
| $8.26M— | —— | ||
| -$51.79M-4.6% | -$49.5M-45.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Alto Neuroscience generate?
- Alto Neuroscience (ANRO) generated -$62.3M in operating cash flow over the trailing twelve months.
- What is Alto Neuroscience's free cash flow?
- After $2.1M of capital expenditures, Alto Neuroscience's free cash flow was -$62.9M over the trailing twelve months, down 14.6% year over year.
- Where does Alto Neuroscience's cash flow data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.